Filing Details
- Accession Number:
- 0001562180-18-003129
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-06-29 16:22:11
- Reporting Period:
- 2018-06-27
- Accepted Time:
- 2018-06-29 16:22:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454001 | Ron Squarer | C/O Array Biopharma Inc. 3200 Walnut Street Boulder CO 80301 | Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-06-27 | 77,881 | $0.00 | 289,456 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-27 | 34,253 | $18.50 | 255,203 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-06-27 | 43,628 | $17.74 | 211,575 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-06-27 | 140,625 | $8.79 | 352,200 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-06-27 | 140,625 | $18.03 | 211,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2018-06-27 | 77,881 | $0.00 | 77,881 | $0.00 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-06-27 | 140,625 | $0.00 | 140,625 | $8.79 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-08-18 | No | 4 | M | Direct | |
| 421,875 | 2026-12-27 | No | 4 | M | Direct |
Footnotes
- Represents shares released on vesting of Restricted Stock Units ("RSUs") granted to the reporting person on August 18, 2014. The grant of these RSUs was previously reported on Table II.
- Represents shares withheld to satisfy tax withholding obligations of the reporting person.
- These trades were made pursuant to a Rule 10b5-1 trading plan.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $17.60 to $17.84. Details of actual prices for shares sold are available from the Issuer upon request.
- The price reported for these shares is the weighted average sale price of transactions made at prices from $17.35 to $18.79. Details of actual prices for shares sold are available from the Issuer upon request.
- RSUs representing 77,881 shares of common stock vested upon the achievement of a second milestone relating to the return of rights to binimetinib to the Issuer on or prior to the fourth anniversary of the grant date, subject to continued service with the Issuer as of the vesting date.
- The options vest in four equal annual installments beginning on December 16, 2017.
Billionaire Hedge Funds
